When diseases infect people at a fair rate without discrimination, why should the treatment for these ailments be unfair? This multidisciplinary model aims at providing every individual in the nation with fair treatment and equal chances of survival.
FREMONT, CA: The European Union is designing a multidisciplinary model to tackle cancer disparities. Approximately 3.5 million Europeans are diagnosed with cancer annually, with a mortal rate of 1.3 million, where 6000 of the affected population are young children. As a result, there is a risk that over 100 million Europeans will be affected by cancer in the upcoming years. With the patients count increasing, the EU is taking a full-fledged measure to battle cancer with the establishment of a special committee on BECA. It evoked awareness regarding available cancer treatments and comprehensive cancer prevention systems.
For equal support, a comprehensive cancer prevention system is proposed as it aims at disposing of geographical boundaries. The committee aims to resolve the disparities in cancer treatments all across the European states and identify the key policy recommendations for the upcoming years. Thus, new policies were formed and implemented, such as investing European funds into new technologies, prevention, examinations, and equalising cancer treatment access in all countries. The comprehensive cancer prevention system includes a standard European diagnosis and treatment for all people in the country. The committee also held campaigns to annihilate the use of alcohol and cigarettes, as their abolition would control the spread of cancer in Europe. Alongside, it also conducts campaigns via 'healthy food signs’ and financial EU information and education campaigns to promote methods to prevent cancer. Thus, the BECA committee mainly focuses on addressing Europe on a whole scale, as it helps patients seek doctors and treatments abroad. Hence, a combined effort will indeed have a great impact on European society.
Furthermore, a new multidisciplinary model will improve the standard of cancer care in underserved communities. Though cancer infection remains indiscriminate, access to its treatments is unequal as certain communities of people benefit while certain others are left all alone to face death. Monumental scientific advancements have led to increasing methods of preventing, diagnosing, and treating cancer ailments.
There are some significant disparities in cancer care, largely affecting people over the age of 65, racial and ethnic minorities, and people living in rural areas. When COVID-19 expanded the health concerns and screened the disparities regarding health, the inequality prevailing in accessing cancer treatments increased. Hence, the magnified health disparities in cancer need to be treated so that the living standards across Europe substantially improve. Hence, with prioritising innovation in oncology, the vital importance of effective cancer diagnosis, treatment, and care is also highlighted. Although development in these areas following COVID-19 has been made, with the anticipated rise in advanced cancer diagnoses on the horizon, the trajectory should be continued and action should be taken. Higher standards in cancer care could be achieved by implementing legislative changes to create a more collaborative, multi-disciplinary model that brings together industry, patient advocacy groups, policymakers, and politicians.
Hence, several medical companies are coming up with innovative medication ideas for cancer patients all over Europe to access medicines. The valuable lesson from COVID-19 is that when people unite for a single goal, extraordinary progress can be made. One such innovative example is "Project Lightspeed". Hence, the new multi-disciplinary model values the expertise of each stakeholder and works in synergy to improve cancer care standards for underserved communities, uniting in the goal of equal cancer treatments for cancer patients.